Humacyte Inc expected to post a loss of 24 cents a share - Earnings Preview

Humacyte

20/03/2024 12:58

* Humacyte Inc  HUMA.OQ   HUMA.O  is expected to show a rise
in
quarterly revenue when it reports  results on March 22 for the
period ending December 31 2023
    * The Durham North Carolina-based  company is expected to
report
revenue of $57.14 thousand, according to the mean estimate from
7 analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Humacyte Inc is for a
loss
of 24 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Humacyte
Inc is
$6.00​, above​ its last closing price of $3.49. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.25       -0.25      -0.25     Met     1.3
 Jun. 30 2023  -0.22       -0.22      -0.22     Met     -0.1
 Mar. 31 2023  -0.21       -0.21      -0.36     Missed  -71.8​
 Dec. 31 2022              -0.23      -0.04     Beat    83
 ​​Sep.        -0.22       -0.21      -0.25     Missed  -16.3
 30 2022                                                
 Jun. 30 2022  -0.22       -0.22      0.35      Beat    260.3​
 Mar. 31 2022  -0.21       -0.21      -0.19     Beat    8.1
 Dec. 31 2021  -0.21       -0.20      0.41      Beat    300
 This summary was machine generated March 20 at 12:58 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)